yeah you're right microtrade...there are plenty of biotechs out there that throw $18M away and setup another $120M in potential milestone payments plus roylaties for limited territories for no good reason.
Plenty of biotechs that demonstrate around 85% success in clinical trials...
Plenty of biotechs that get granted priority review by the FDA to fast track approval processes for no good reason...
Plenty of aussie biotechs on the cusp of getting FDA approval for a new drug (by themselves) where there is no other viable option in the market place and planning to sell to the US market H1 of this year....
Yeah...no hope for this company.
2 weeks to go..., page-14
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)